Tandem Diabetes Care (TNDM) Cash from Operations (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Cash from Operations for 14 consecutive years, with -$34.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Operations fell 264.68% year-over-year to -$34.6 million; the trailing twelve-month figure through Jun 2026 stood at -$5.5 million (down 156.81% YoY), and the FY2025 full-year result was -$9.7 million, down 140.13% from the prior year.
• Cash from Operations retreated to -$34.6 million in Q2 2026 per TNDM's latest filing, from $11.1 million in the prior quarter.
• Across five years, Cash from Operations topped out at $26.8 million in Q3 2024 and bottomed at -$34.6 million in Q2 2026.
• Historically, Cash from Operations has averaged $532333.3 across 5 years, with a median of $2.9 million in 2022.
• The sharpest annual moves came in 2024 and 2026: Cash from Operations soared 48589.09% in 2024, then sank 264.68% in 2026.
• Over 5 years, Cash from Operations stood at $5.8 million in 2022, then tumbled by 223.99% to -$7.2 million in 2023, then jumped by 248.52% to $10.7 million in 2024, then fell by 8.66% to $9.8 million in 2025, then sank by 453.76% to -$34.6 million in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered -$34.6 million, $11.1 million, and $9.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.